Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
Spierings, Egilius LH, Brandes, Jan Lewis, Kudrow, David B, Weintraub, James, Schmidt, Peter C, Kellerman, Donald J, Tepper, Stewart JLanguage:
english
Journal:
Cephalalgia
DOI:
10.1177/0333102417737765
Date:
October, 2017
File:
PDF, 343 KB
english, 2017